Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Astroglioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT03181477
What this trial is testing

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

Who this might be right for
Glioblastoma, Adult
Centre Georges Francois Leclerc 67
Testing effectiveness (Phase 2)Ended earlyNCT01721577
What this trial is testing

Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more
Rush University Medical Center 10
Not applicableEnded earlyNCT02329795
What this trial is testing

Image-derived Prediction of Response to Chemo-radiation in Glioblastoma

Who this might be right for
Glioblastoma
Rigshospitalet, Denmark 16
Testing effectiveness (Phase 2)UnknownNCT05447195
What this trial is testing

Phase 2 Study of CAN008 in Subjects With GBM

Who this might be right for
Newly-diagnosed Glioblastoma
CANbridge Life Sciences Ltd. 117
Large-scale testing (Phase 3)Ended earlyNCT03419403
What this trial is testing

UNITE Study: Understanding New Interventions With GBM ThErapy

Who this might be right for
Glioblastoma Multiforme
AbbVie 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07758062
What this trial is testing

Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma

Who this might be right for
Glioblastoma
Tianjin Medical University General Hospital 140
Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Early research (Phase 1)Active Not RecruitingNCT05226494
What this trial is testing

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma

Who this might be right for
Glioma, Malignant
NanoPharmaceuticals LLC 34
Testing effectiveness (Phase 2)Temporarily pausedNCT06329570
What this trial is testing

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioma+3 more
NaviFUS Corporation 10
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Testing effectiveness (Phase 2)Study completedNCT01120639
What this trial is testing

Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform

Who this might be right for
GlioblastomaCancer of Brain and Nervous SystemGlioblastoma Multiforme
Stanford University 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06477939
What this trial is testing

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

Who this might be right for
Glioblastoma
Institut de cancérologie Strasbourg Europe 554
Early research (Phase 1)Looking for participantsNCT05686798
What this trial is testing

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+6 more
Henry Ford Health System 18
Not applicableLooking for participantsNCT06533163
What this trial is testing

Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial

Who this might be right for
Glioblastoma Multiforme
BioTex, Inc. 30
Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Early research (Phase 1)Study completedNCT01800695
What this trial is testing

Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
AbbVie 202
Testing effectiveness (Phase 2)Study completedNCT00612339
What this trial is testing

Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas

Who this might be right for
GlioblastomaGliosarcoma
Duke University 41
Early research (Phase 1)Looking for participantsNCT07145112
What this trial is testing

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of California, Davis 20
Early research (Phase 1)Study completedNCT00077454
What this trial is testing

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Next Page